Stratification of radiosensitive brain metastases based on an actionable S100A9/RAGE resistance mechanism C Monteiro, L Miarka, M Perea-García, N Priego, P Garcia-Gomez, ... Nature Medicine 28 (4), 752-765, 2022 | 37 | 2022 |
Immune-related adverse events and atypical radiological response with checkpoint inhibitor immunotherapy in an elderly patient with high PD-L1 expressing lung adenocarcinoma E Teixidor, E Sais, CA Vásquez, W Carbajal, A Hernández, G Sánchez, ... Oncotarget 9 (68), 33043, 2018 | 11 | 2018 |
The dark side of immunotherapy: challenges facing the new hope in cancer treatment E Teixidor, J Bosch-Barrera Annals of Translational Medicine, 2019 | 7 | 2019 |
Silibinin overcomes EMT-Driven lung cancer resistance to New-Generation ALK inhibitors S Verdura, JA Encinar, E Teixidor, A Segura-Carretero, V Micol, E Cuyàs, ... Cancers 14 (24), 6101, 2022 | 4 | 2022 |
Clinical management of COVID-19 in cancer patients with the STAT3 inhibitor silibinin J Bosch-Barrera, A Roqué, E Teixidor, MC Carmona-Garcia, A Arbusà, ... Pharmaceuticals 15 (1), 19, 2021 | 2 | 2021 |
Silibinin is a suppressor of the metastasis-promoting transcription factor ID3 S Verdura, JA Encinar, A Gratchev, À Llop-Hernández, J López, ... Phytomedicine, 155493, 2024 | | 2024 |
EP02. 01-05 Using Silibinin to Target STAT3-Positive Reactive Astrocytes for the Treatment of NSCLC Brain Metastases J Bosch-Barrera, E Teixidor, A Sanvisens, M Puigdemont, J Trallero, ... Journal of Thoracic Oncology 18 (11), S426-S427, 2023 | | 2023 |
Addendum: Immune-related adverse events and atypical radiological response with checkpoint inhibitor immunotherapy in an elderly patient with high PD-L1 expressing lung … E Teixidor, E Sais, CA Vásquez, W Carbajal, A Hernández, G Sánchez, ... Oncotarget 14, 668, 2023 | | 2023 |
P2. 01-49 Targeting STAT3-Positive Reactive Astrocytes with Silibinin in the Therapeutic Landscape of Non-Small-Cell Lung Cancer with Brain Metastases J Bosch-Barrera, N Priego, M Puigdemont, E Sais, N Quer, A Izquierdo, ... Journal of Thoracic Oncology 14 (10), S658, 2019 | | 2019 |
P1. 03-035 Efficacy of Nintedanib and Docetaxel in Combination with the Nutraceutical Use of Silibinin in Advanced NSCLC JB Barrera, E Sais, S Verdura, E Cuyas, D Roa, A Hernández, A Izquierdo, ... Journal of Thoracic Oncology 12 (11), S1964, 2017 | | 2017 |